AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Seres Therapeutics, Inc. Director's Dealing 2021

Jun 1, 2021

33847_dirs_2021-06-01_896374a6-a986-48a5-aaa3-f80433544392.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Seres Therapeutics, Inc. (MCRB)
CIK: 0001609809
Period of Report: 2021-06-01

Reporting Person: Arkowitz David (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2000	Direct